IL0006290147
IL0006290147
TEVA PHARMA IND
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 17.257.000.000 | 16.544.000.000 | 4.3% |
| Cost of Revenue | 8.320.000.000 | 8.481.000.000 | 1.9% |
| Gross Profit | 8.938.000.000 | 8.064.000.000 | 10.8% |
| 4.986.000.000 | 4.700.000.000 | 6.1% | |
| Operating Income | 3.952.000.000 | 3.364.000.000 | 17.5% |
| Pretax Income | 1.223.000.000 | -1.284.000.000 | 195.2% |
| Net Income Common Stockholders | 1.410.000.000 | -1.639.000.000 | 186.0% |
| -- | -- | -- | |
| -- | -- | -- |